Stonepine Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Stonepine Capital Management’s Portfolio ACRS Stock Details ACRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$367K	Sell
2025 Q2	$698K	Sell
2025 Q1	$2.77M	Sell
2024 Q4	$1.65M	Sell
2024 Q3	$2.83M	Buy
2024 Q2	$2.12M	Buy